Vetrugno G C, Lachuer J, Perego C, Miranda E, De Simoni M G, Tappaz M
Instituto di Ricerche Farmacologiche Mario Negri, Milano, Italia.
Neuroendocrinology. 1993 May;57(5):835-42. doi: 10.1159/000126442.
The release of endogenous noradrenaline in the anterior hypothalamus was studied with microdialysis perfusion in freely moving rats that were subjected to immobilization stress. Experiments were carried out in sham-adrenalectomized and adrenalectomized rats that were first given drinking water containing corticosterone for 5 days following surgery and then switched to a corticosterone-free diet the day before stress application. One group of these adrenalectomized animals was injected with dexamethasone. Basal release of noradrenaline collected in 20-min fractions was similar in the three groups of animals and averaged 24 fmol. The recovery of the probe was about 10%. In sham-adrenalectomized rats application of 20-min immobilization stress increased noradrenaline release to 310% of baseline in the sample collected during stress application. A significant increase (+ 175% of baseline) was still observed in the next 20-min sample. Subsequent values were all identical to baseline. In adrenalectomized rats lacking exogenous corticosterone the stress-induced release of noradrenaline was prolonged with noradrenaline levels remaining elevated for 2 h after the onset of stress. The total noradrenaline release during this entire period was about 2.5 times higher in adrenalectomized than in sham-operated rats. However, the maximal increase during the period of immobilization was not significantly affected. Treatment with dexamethasone prevented the prolonged increase in noradrenaline release but did not affect the increase during the period of stress. While glucocorticoids do not appear to affect the increased release of NA in the anterior hypothalamus during the period of stress, they act to limit the duration of this activation after the application of stress.(ABSTRACT TRUNCATED AT 250 WORDS)
采用微透析灌注技术,在自由活动且遭受固定应激的大鼠中,研究下丘脑前部内源性去甲肾上腺素的释放。实验在假手术切除肾上腺和切除肾上腺的大鼠中进行,这些大鼠术后先饮用含皮质酮的水5天,然后在施加应激前一天改为无皮质酮饮食。其中一组切除肾上腺的动物注射了地塞米松。以20分钟为间隔收集的去甲肾上腺素基础释放量在三组动物中相似,平均为24飞摩尔。探针回收率约为10%。在假手术切除肾上腺的大鼠中,施加20分钟的固定应激使应激期间收集的样本中去甲肾上腺素释放量增加至基线的310%。在下一个20分钟样本中仍观察到显著增加(+175%基线)。随后的值均与基线相同。在缺乏外源性皮质酮的切除肾上腺的大鼠中,应激诱导的去甲肾上腺素释放延长,应激开始后2小时内去甲肾上腺素水平持续升高。在整个这段时间内,切除肾上腺的大鼠去甲肾上腺素总释放量比假手术大鼠高约2.5倍。然而,固定期间的最大增加量未受到显著影响。地塞米松治疗可防止去甲肾上腺素释放的延长增加,但不影响应激期间的增加。虽然糖皮质激素似乎不影响应激期间下丘脑前部去甲肾上腺素释放的增加,但它们在应激施加后起到限制这种激活持续时间的作用。(摘要截短至250字)